-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$15,300.00133992.9% Upside
Finch Therapeutics Group, Inc. Frequently Asked Questions
-
What analysts cover Finch Therapeutics Group, Inc.?
Finch Therapeutics Group, Inc. has been rated by research analysts at Jefferies in the past 90 days.